Seth Loring Harrison - Net Worth and Insider Trading
Seth Loring Harrison Net Worth
The estimated net worth of Seth Loring Harrison is at least $187 Million dollars as of 2025-04-27. Seth Loring Harrison is the Director, 10% Owner of Stoke Therapeutics Inc and owns about 17,161,713 shares of Stoke Therapeutics Inc (STOK) stock worth over $167 Million. Seth Loring Harrison is the Director of Akero Therapeutics Inc and owns about 284,364 shares of Akero Therapeutics Inc (AKRO) stock worth over $12 Million. Seth Loring Harrison is also the Director of Heartware International Inc and owns about 139,143 shares of Heartware International Inc (HTWR) stock worth over $8 Million. Details can be seen in Seth Loring Harrison's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seth Loring Harrison has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Seth Loring Harrison
Seth Loring Harrison Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seth Loring Harrison owns 6 companies in total, including Akero Therapeutics Inc (AKRO) , Stoke Therapeutics Inc (STOK) , and Heartware International Inc (HTWR) among others .
Click here to see the complete history of Seth Loring Harrison’s form 4 insider trades.
Insider Ownership Summary of Seth Loring Harrison
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2022-11-30 | director |
| STOK | Stoke Therapeutics Inc | 2020-11-24 | director & 10 percent owner |
| HTWR | Heartware International Inc | 2016-08-23 | director |
 | | 2014-09-16 | director & 10 percent owner |
| | 2015-10-14 | director & 10 percent owner |
| | 2013-11-25 | 10 percent owner |
Seth Loring Harrison Latest Holdings Summary
Seth Loring Harrison currently owns a total of 3 stocks. Among these stocks, Seth Loring Harrison owns 17,161,713 shares of Stoke Therapeutics Inc (STOK) as of November 24, 2020, with a value of $167 Million and a weighting of 89.46%. Seth Loring Harrison owns 284,364 shares of Akero Therapeutics Inc (AKRO) as of November 30, 2022, with a value of $12 Million and a weighting of 6.23%. Seth Loring Harrison also owns 139,143 shares of Heartware International Inc (HTWR) as of January 6, 2014, with a value of $8 Million and a weighting of 4.31%.
Latest Holdings of Seth Loring Harrison
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2020-11-24 | 17,161,713 | 9.76 | 167,498,319 |
| AKRO | Akero Therapeutics Inc | 2022-11-30 | 284,364 | 41.00 | 11,658,924 |
| HTWR | Heartware International Inc | 2014-01-06 | 139,143 | 57.98 | 8,067,511 |
Holding Weightings of Seth Loring Harrison
Seth Loring Harrison Form 4 Trading Tracker
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 1 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Stoke Therapeutics Inc is the acquisition of 375,000 shares on November 24, 2020, which cost Seth Loring Harrison around $15 Million.
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 4 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 23,131 shares on November 30, 2022, which brought Seth Loring Harrison around $1 Million.
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 0 transactions in Heartware International Inc (HTWR) over the past 5 years. The most-recent trade in Heartware International Inc is the sale of 7,909 shares on January 6, 2014, which brought Seth Loring Harrison around $785,285.
Insider Trading History of Seth Loring Harrison
- 1
Seth Loring Harrison Trading Performance
GuruFocus tracks the stock performance after each of Seth Loring Harrison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seth Loring Harrison is -1.56%. GuruFocus also compares Seth Loring Harrison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seth Loring Harrison within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seth Loring Harrison's insider trading performs compared to the benchmark.
Performance of Seth Loring Harrison
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.62 | | | | | |
| Relative Return to S&P 500(%) | 2.93 | | | | | |
Seth Loring Harrison Ownership Network
Ownership Network List of Seth Loring Harrison
Ownership Network Relation of Seth Loring Harrison
Seth Loring Harrison Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Seth Loring Harrison is the director of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Development Officer Catriona Yale , director & President & CEO Andrew Cheng , and Chief Scientific Officer Timothy Rolph .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Seth Loring Harrison made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 258,578 shares made by Catriona Yale , a net sale of 253,518 shares made by Jonathan Young , and a net sale of 469,800 shares made by Andrew Cheng .
In summary, during the past 3 months, insiders sold 209,224 shares of Akero Therapeutics Inc (AKRO) in total and bought 400,000 shares, with a net purchase of 190,776 shares. During the past 18 months, 1,363,122 shares of Akero Therapeutics Inc (AKRO) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 763,122 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Seth Loring Harrison Mailing Address
Above is the net worth, insider trading, and ownership report for Seth Loring Harrison. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Seth Loring Harrison's mailing address is: New York Ny 10169.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
